Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.

@article{Kim2008TreatmentOO,
  title={Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.},
  author={Tae Hee Kim and Yoon Ho Ko and Myung Ah Lee and Bum-soo Kim and So Ryoung Chung and Ie Ryung Yoo and C J Jung and Yeon Sil Kim and Min-Sik Kim and Dong-Il Sun and Young Seon Hong and K yung Shik Lee and Jin-Hyoung Kang},
  journal={Cancer research and treatment : official journal of Korean Cancer Association},
  year={2008},
  volume={40 2},
  pages={62-70}
}
PURPOSE The standard treatment of locally advanced nasopharyngeal cancer is a concurrent chemoradiotherapy (CCRT), and cisplatin has been used as the most popular chemotherapeutic agent. But many different doses and schedules for cisplatin administration such as daily, weekly and 3 week cycles have been proposed. We compared and analyzed the tumor response… CONTINUE READING